ROCKVILLE, Md., July 30, 2020 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and […]
NOT FOR RELEASE OR DISSEMINATION INTO THE UNITED STATESQ2 2020 Financial Highlights(1):Revenues increased 7.1% to $412.9 millionGross Margin increased to […]